Literature DB >> 27655221

Microvascular endothelial dysfunction in heart failure with preserved ejection fraction.

Carolyn S P Lam1, Lars H Lund2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27655221     DOI： 10.1136/heartjnl-2015-308852

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  8 in total

1.  The midrange left ventricular ejection fraction (LVEF) is associated with higher all-cause mortality during the 1-year follow-up compared to preserved LVEF among real-world patients with acute heart failure: a single-center propensity score-matched analysis.

Authors:  Josip Anđelo Borovac; Katarina Novak; Josko Bozic; Duska Glavas
Journal:  Heart Vessels       Date:  2018-08-29       Impact factor: 2.037

2.  Incident Hospitalization with Major Cardiovascular Diseases and Subsequent Risk of ESKD: Implications for Cardiorenal Syndrome.

Authors:  Junichi Ishigami; Logan T Cowan; Ryan T Demmer; Morgan E Grams; Pamela L Lutsey; Juan-Jesus Carrero; Josef Coresh; Kunihiro Matsushita
Journal:  J Am Soc Nephrol       Date:  2020-01-09       Impact factor: 10.121

Review 3.  Innovative Clinical Trial Designs for Precision Medicine in Heart Failure with Preserved Ejection Fraction.

Authors:  Sanjiv J Shah
Journal:  J Cardiovasc Transl Res       Date:  2017-07-05       Impact factor: 4.132

4.  Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF.

Authors:  Sanjiv J Shah; Carolyn S P Lam; Sara Svedlund; Antti Saraste; Camilla Hage; Ru-San Tan; Lauren Beussink-Nelson; Ulrika Ljung Faxén; Maria Lagerström Fermer; Malin A Broberg; Li-Ming Gan; Lars H Lund
Journal:  Eur Heart J       Date:  2018-10-01       Impact factor: 29.983

Review 5.  Growth differentiation factor 15 in adverse cardiac remodelling: from biomarker to causal player.

Authors:  Marian Wesseling; Julius H C de Poel; Saskia C A de Jager
Journal:  ESC Heart Fail       Date:  2020-05-18

6.  Myeloperoxidase and related biomarkers are suggestive footprints of endothelial microvascular inflammation in HFpEF patients.

Authors:  Camilla Hage; Erik Michaëlsson; Bengt Kull; Tasso Miliotis; Sara Svedlund; Cecilia Linde; Erwan Donal; Jean-Claude Daubert; Li-Ming Gan; Lars H Lund
Journal:  ESC Heart Fail       Date:  2020-05-19

Review 7.  Use of Renin-Angiotensin-Aldosterone System Inhibitors in Older Patients with Heart Failure and Reduced Ejection Fraction.

Authors:  Davide Stolfo; Gianluigi Savarese
Journal:  Card Fail Rev       Date:  2019-05-24

8.  Evaluation of left ventricular systolic function in patients with different types of ischemic heart disease by two-dimensional speckle tracking imaging.

Authors:  Xing Xing; Dan Li; Shaomin Chen; Lingli Wang; Zhaoping Li; Liyun He
Journal:  J Cardiothorac Surg       Date:  2020-11-04       Impact factor: 1.637
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.